<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/455203A4-9781-4725-A589-223CA5AD2E10"><gtr:id>455203A4-9781-4725-A589-223CA5AD2E10</gtr:id><gtr:name>Australian National University (ANU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/455203A4-9781-4725-A589-223CA5AD2E10"><gtr:id>455203A4-9781-4725-A589-223CA5AD2E10</gtr:id><gtr:name>Australian National University (ANU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/94B25A1E-8749-47FE-9207-256E6A029A45"><gtr:id>94B25A1E-8749-47FE-9207-256E6A029A45</gtr:id><gtr:firstName>Sylvie</gtr:firstName><gtr:surname>Freeman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DC63EDA7-0B90-486C-A754-582C3D1B34A3"><gtr:id>DC63EDA7-0B90-486C-A754-582C3D1B34A3</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Calman</gtr:otherNames><gtr:surname>MacLennan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/16B653E2-0DEA-4EC3-BEB0-B755754726BD"><gtr:id>16B653E2-0DEA-4EC3-BEB0-B755754726BD</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Buckley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G8402371"><gtr:id>EB32F80D-4093-4DD1-9966-9438453FD39F</gtr:id><gtr:title>Regulation of extrafollicular antibody responses and plasma cell survival</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G8402371</gtr:grantReference><gtr:abstractText>We have a range of mechanisms that give us an inherent ability to recognize and eliminate most infections. Nevertheless, some viruses and bacteria evade these defences and in this situation antibodies play a key role in protecting us from serious infection. When we have not encountered a particular infection previously there may be no pre-existing antibody that is able to control its spread. In this situation the speed of production of antibody is critical if the infection is to be limited and severe disease prevented. The proposed programme is focusing on the early production of antibody in response to infection. The studies will based on previous work in the laboratory which has shown that the cells that give rise to antibody ? B cells ? have to receive a series of signals in a succession of microenvironments as they mature to antibody producing cells. The nature of these signals varies with the type of infection and this variation affects the speed of the response as well as the amount and type of antibody produced. Suboptimal response of the B cells at any stage for genetic or environmental reasons can result in an unfavourable outcome to the infection. The programme seeks to identify how these antibody responses can be modified to secure optimal protection.
A second part of the programme will characterise the cells in certain tissues such as the bone marrow and spleen that are required to sustain secrete antibody cells. Understanding how these cells support antibody production may suggest ways in which the levels of antibodies produced can be modified. This becomes particularly relevant when one considers that sometimes the complex mechanisms that control responses against infections fail and antibodies are made that can bind to and lead to damage of healthy tissue. Such antibodies are known as autoantibodies. The programme will investigate how autoantibody production is sustained in Sjogrens syndrome and rheumatoid arthritis. There is reason to suppose that cells that sustain the production of autoantibodies in these patients show differences in location and character from those that support the production of protective antibody. Identifying the molecular basis of these differences may make it possible selectively to curtail the function of cells that support autoantibody production.</gtr:abstractText><gtr:technicalSummary>Extrafollicular antibody responses provide first line adaptive humoral defence in infection. These responses produce neutralizing antibody that limits the spread of many viral infections and opsonizing antibody against antigens that do not elicit T cell help, such as bacterial capsular polysaccharides. Many features of adaptive antibody responses are shaped by innate immune signals. These can directly or indirectly influence the number and type of B cell recruited, the class of antibody produced, and the proportion of cells that mature to become antibody-secreting cells. The current programme has shown that B cells pass through four distinct microenvironments during extrafollicular antibody responses. The first objective of the new programme is to identify the nature of the signals responsible for regulating extrafollicular responses in each of these sites with particular reference to the initial induction of follicular or extrafollicular growth, immunoglobulin classes switching, as well as the control of plasmablast growth, differentiation and survival. The second aim is to study the tissue beds that support antibody-secreting cells and secure long-term antibody production. Long-lived plasma cells that reside in the bone marrow and to a lesser extent in the spleen produce most of the IgG and monomeric IgA found in blood. The programme will test how plasma cells gain access to these stromal beds and the mechanisms that allow newly-produced plasma cells to partially displace pre-existing residents. The programme brings together groups from Birmingham and Berlin that have experience in studies characterising long-lived plasma cells with other groups in the University of Birmingham, MRC Centre for Immune Regulation that study stromal cells that support inflammation and haemopoiesis. Techniques used to characterise differences between the stroma in different inflammatory beds will be used to identify analogous variation in the different plasma cells beds that support long-term antibody production. There will be parallel studies on stromal cells that support plasma cells in the spleen and bone marrow in mice and those in human tonsil and bone marrow. This will lead to analysis of ectopic plasma cell beds in salivary tissue of patients with Sjogren?s disease and suspected expansion of the bone marrow plasma cell beds in patients with rheumatoid arthritis. These studies should provide information about the way autoantibody levels are sustained and may lead to novel therapeutic approaches that reduce levels of pathogenic autoantibodies.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1984-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>6150032</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Protective and inhibitory antibodies against Salmonella</gtr:description><gtr:id>4DA07C3B-6528-4CEB-9212-136D2B019F03</gtr:id><gtr:impact>Several papers on the nature and targets for protective immunity against bacteraemia and meningitis in non-Typhoidal Salmonella infection are listed in the publications comming from this grant. Dr Calman MacLennan has recently moved to Head of Exploratory Programme at the Novartis Vaccines Institute for Global Health in Sienna and is applying research coming from the programme to the development of a vaccine to protect patients, particularly from Africa, from the extracellular growth of non-Typhoidal Salmonella. This infection is a major health problem in children from sub-Saharan Africa and patients with AIDS.</gtr:impact><gtr:partnerContribution>These collaborations with the goups of Adam Cunningham and Calman MacLennan have increased our understanding of protective immunity against bacteraemia and meningitis with non-Typhoidal Salmonella. They are assisting vaccine development in collaboration with Novartis Vaccines Institute for Global Health in Siena. Key publications from this work include: PMID: 19487686, PMID: 20413503</gtr:partnerContribution><gtr:piContribution>Through working out the nature of antibody responses against against non-typhoidal Salmonella and identifying targets for protective immunity agaist bacteraemia and meningitis with these microorganisms</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Australian National University (ANU)</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>John Curtin School of Medical Research (JCSMR)</gtr:department><gtr:description>studies on the regulation of antibody responses</gtr:description><gtr:id>8B698AA5-ECB9-4A4C-BAEF-AF9633085561</gtr:id><gtr:impact>This work has 2 outputs i) The identification of B1b cells as key players in T independent antibody responses and the demonstration that these cells form T-independent memory. This work was published in PNAS USA PMID: 16585532 ii) Identification of novel molecules expressed by germinal centre B cells PMID: 17938642</gtr:impact><gtr:partnerContribution>Intelectual and practical contributions</gtr:partnerContribution><gtr:piContribution>This collaboration represents continued research started when Carola Vinuesa was an MRC clinical research training fellow in Ian MacLennan's laboratory. It is work initiated in Ian MacLennan's lab</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>microRNA-155 regulating the generation of immunoglobulin class-switched plasma cells</gtr:description><gtr:id>348926CE-4B4E-497C-947E-18552DCB42B7</gtr:id><gtr:impact>This study provided new information on the regulation of immunoglobulin class swiching and was published in Immunity PMID: 18055230</gtr:impact><gtr:partnerContribution>Complementary assistance by providing expertise in micro RNA technology</gtr:partnerContribution><gtr:piContribution>We assessed the relative effect of microRNA-155 deficiency on germinal centre and extrafollicular antibody respoonses and its differential effect on somatic hypermutation and Ig class switching</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>17500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leverhulme Emeritus Fellowship</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>The Leverhulme Trust</gtr:fundingOrg><gtr:id>4E489239-985C-4DB0-B8AC-C2809316E3ED</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/965DBE09-90A1-4DA6-8C02-161FDAEF5AB4"><gtr:id>965DBE09-90A1-4DA6-8C02-161FDAEF5AB4</gtr:id><gtr:title>Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/826cdc2ce0980c0b971111b73991889a"><gtr:id>826cdc2ce0980c0b971111b73991889a</gtr:id><gtr:otherNames>MacLennan CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86794182-174B-4703-B1D9-65807D1C2DEB"><gtr:id>86794182-174B-4703-B1D9-65807D1C2DEB</gtr:id><gtr:title>Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8722cf85af88fedef71a8a5f75ecdf1"><gtr:id>a8722cf85af88fedef71a8a5f75ecdf1</gtr:id><gtr:otherNames>Mohr E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB7636EC-87E4-491C-AA3A-E3D365188CB2"><gtr:id>FB7636EC-87E4-491C-AA3A-E3D365188CB2</gtr:id><gtr:title>T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA1F477D-F26A-43E6-A043-796410C35FA6"><gtr:id>CA1F477D-F26A-43E6-A043-796410C35FA6</gtr:id><gtr:title>CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB11599A-B7AE-48B5-A5B3-A0733DF3E969"><gtr:id>CB11599A-B7AE-48B5-A5B3-A0733DF3E969</gtr:id><gtr:title>Axon growth and guidance genes identify T-dependent germinal centre B cells.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/547f807dc0ebfcdc83f554f5aca958ab"><gtr:id>547f807dc0ebfcdc83f554f5aca958ab</gtr:id><gtr:otherNames>Yu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9964E3FE-96E4-4ABC-8A20-A2856B3B9698"><gtr:id>9964E3FE-96E4-4ABC-8A20-A2856B3B9698</gtr:id><gtr:title>Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ff27e2ac4df3054f0117b04cf415acb"><gtr:id>7ff27e2ac4df3054f0117b04cf415acb</gtr:id><gtr:otherNames>Cunningham AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9AE5E5A5-3CFE-4C33-AB0A-B905C9D40109"><gtr:id>9AE5E5A5-3CFE-4C33-AB0A-B905C9D40109</gtr:id><gtr:title>Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/090770ae85e08aea4f8baa330abeb34d"><gtr:id>090770ae85e08aea4f8baa330abeb34d</gtr:id><gtr:otherNames>Bobat S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0EF408A7-05CB-4CFA-8F6C-E5DE23AA8D0D"><gtr:id>0EF408A7-05CB-4CFA-8F6C-E5DE23AA8D0D</gtr:id><gtr:title>Critical synergy of CD30 and OX40 signals in CD4 T cell homeostasis and Th1 immunity to Salmonella.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2d119d2d28732637a596a12677acdfb"><gtr:id>c2d119d2d28732637a596a12677acdfb</gtr:id><gtr:otherNames>Gaspal F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7989B6B-1112-4325-9A15-17E25132A0FD"><gtr:id>F7989B6B-1112-4325-9A15-17E25132A0FD</gtr:id><gtr:title>IL-4 directs both CD4 and CD8 T cells to produce Th2 cytokines in vitro, but only CD4 T cells produce these cytokines in response to alum-precipitated protein in vivo.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5E0137E-C274-417D-9D07-6EE8A9690847"><gtr:id>B5E0137E-C274-417D-9D07-6EE8A9690847</gtr:id><gtr:title>Holding antigen where B cells can find it.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/015b2c04924199300004f8c07c17f3f6"><gtr:id>015b2c04924199300004f8c07c17f3f6</gtr:id><gtr:otherNames>MacLennan I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D507281C-DAB4-4F7E-A9A1-FA62A1ACE5C3"><gtr:id>D507281C-DAB4-4F7E-A9A1-FA62A1ACE5C3</gtr:id><gtr:title>Selective effects of NF-?B1 deficiency in CD4? T cells on Th2 and TFh induction by alum-precipitated protein vaccines.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/266BBD27-BE76-46D7-B6B4-620794AB954D"><gtr:id>266BBD27-BE76-46D7-B6B4-620794AB954D</gtr:id><gtr:title>The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/38e50117f77a619640c23aad9a8a1599"><gtr:id>38e50117f77a619640c23aad9a8a1599</gtr:id><gtr:otherNames>Marshall JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/04156020-1D31-4FD2-BCED-924E40AC3BD6"><gtr:id>04156020-1D31-4FD2-BCED-924E40AC3BD6</gtr:id><gtr:title>Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A01F2E6A-E9B4-47C1-8B68-113D8F36F26B"><gtr:id>A01F2E6A-E9B4-47C1-8B68-113D8F36F26B</gtr:id><gtr:title>Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/38e50117f77a619640c23aad9a8a1599"><gtr:id>38e50117f77a619640c23aad9a8a1599</gtr:id><gtr:otherNames>Marshall JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76C58749-C1E2-4C55-85B2-DC364A2610A5"><gtr:id>76C58749-C1E2-4C55-85B2-DC364A2610A5</gtr:id><gtr:title>Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5e6abe8abf2eea0e95a263b57fa92e1"><gtr:id>c5e6abe8abf2eea0e95a263b57fa92e1</gtr:id><gtr:otherNames>Winter O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D443E1A-0F8D-493A-8CB4-FF745ECFEE63"><gtr:id>4D443E1A-0F8D-493A-8CB4-FF745ECFEE63</gtr:id><gtr:title>IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8722cf85af88fedef71a8a5f75ecdf1"><gtr:id>a8722cf85af88fedef71a8a5f75ecdf1</gtr:id><gtr:otherNames>Mohr E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB867D52-094D-4B7A-9BD6-8675B63FFC04"><gtr:id>DB867D52-094D-4B7A-9BD6-8675B63FFC04</gtr:id><gtr:title>CD8 T cells induce T-bet-dependent migration toward CXCR3 ligands by differentiated B cells produced during responses to alum-protein vaccines.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EC0A7A6-46E5-4DEC-80B6-6498C3A16ADC"><gtr:id>4EC0A7A6-46E5-4DEC-80B6-6498C3A16ADC</gtr:id><gtr:title>Molecular differences between the divergent responses of ovalbumin-specific CD4 T cells to alum-precipitated ovalbumin compared to ovalbumin expressed by Salmonella.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1BC39BC2-CBEE-4175-B54E-51DB1D22C6B9"><gtr:id>1BC39BC2-CBEE-4175-B54E-51DB1D22C6B9</gtr:id><gtr:title>Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cb4eaa54ac5dd86e3b09eae12698bc4e"><gtr:id>cb4eaa54ac5dd86e3b09eae12698bc4e</gtr:id><gtr:otherNames>Ferraro AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/331B3880-9F7E-4ED7-8A1E-DD9D098AB93D"><gtr:id>331B3880-9F7E-4ED7-8A1E-DD9D098AB93D</gtr:id><gtr:title>B cell clones that sustain long-term plasmablast growth in T-independent extrafollicular antibody responses.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9eb265d213c75ac19e11f7a0d0a3cc4"><gtr:id>a9eb265d213c75ac19e11f7a0d0a3cc4</gtr:id><gtr:otherNames>Hsu MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/87B88B3A-6833-4638-BA29-A58A02507B52"><gtr:id>87B88B3A-6833-4638-BA29-A58A02507B52</gtr:id><gtr:title>B cells: the follicular dimension of the marginal zone.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ac170df2fcba465bfd3f8315f7e0697"><gtr:id>1ac170df2fcba465bfd3f8315f7e0697</gtr:id><gtr:otherNames>MacLennan IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC557409-2E17-429A-8462-97F25C586F65"><gtr:id>EC557409-2E17-429A-8462-97F25C586F65</gtr:id><gtr:title>Recirculating CD4 memory T cells mount rapid secondary responses without major contributions from follicular CD4 effectors and B cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e9b6863bfe47c564aaacbdd5463b4d3"><gtr:id>6e9b6863bfe47c564aaacbdd5463b4d3</gtr:id><gtr:otherNames>Luther SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3289C22B-0A2C-4432-8FC3-6DF32065CBDB"><gtr:id>3289C22B-0A2C-4432-8FC3-6DF32065CBDB</gtr:id><gtr:title>HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f84a595d1ec65fe050e4f11ea28f208f"><gtr:id>f84a595d1ec65fe050e4f11ea28f208f</gtr:id><gtr:otherNames>Capasso M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/18A346EC-F91C-477A-B8AD-916EFD110735"><gtr:id>18A346EC-F91C-477A-B8AD-916EFD110735</gtr:id><gtr:title>Early simultaneous production of intranodal CD4 Th2 effectors and recirculating rapidly responding central-memory-like CD4 T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A39EF7E-C320-48A4-A4D7-3EC08D920FEA"><gtr:id>9A39EF7E-C320-48A4-A4D7-3EC08D920FEA</gtr:id><gtr:title>The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac7a6d7d0e33498ac7e643f15a8a12b9"><gtr:id>ac7a6d7d0e33498ac7e643f15a8a12b9</gtr:id><gtr:otherNames>Gil-Cruz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAFEA066-2FF1-4FF0-AD36-EA5C9EF9CCF2"><gtr:id>CAFEA066-2FF1-4FF0-AD36-EA5C9EF9CCF2</gtr:id><gtr:title>microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G8402371</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>